CCSD code N1350 – Exploration of testis

Key takeaways

CCSD Code N1350 covers surgical exploration of the testis, and a biopsy taken in the same session is part of the same code.

Billing a separate biopsy code alongside N1350 is duplicate billing and a common audit trigger.

If the testis is fixed or removed in the same session, the orchidopexy or orchidectomy code replaces N1350.

Most UK private medical insurers require pre-authorisation before a non-emergency N1350 procedure, and a missing authorisation number is a leading cause of denial.

Pabau, the practice management platform we build, tracks the authorisation code on the patient’s case and submits CCSD-coded claims through Healthcode.

What is CCSD Code N1350?

CCSD Code N1350 is the procedure code for surgical exploration of the testis, including a biopsy when one is taken during the same operation. CCSD stands for Clinical Coding and Schedule Development.

The schedule is maintained by the CCSD Group, whose members are four private medical insurers: Bupa, Vitality, AXA Health and Aviva. UK private practices use it to invoice insurers and submit claims.

The official descriptor reads Exploration of testis (including biopsy). The parenthetical makes the code inclusive of biopsy. If the surgeon explores the testis and takes a tissue sample in the same session, N1350 covers both, and no separate biopsy code is added.

The code sits in the genitalia section of the CCSD chapter on the urinary system and male reproductive organs. Its neighbours there include the orchidopexy and orchidectomy codes.

What the procedure involves

Surgical exploration of the testis is performed under general or regional anaesthesia, through a scrotal or inguinal incision. A scrotal incision delivers the testis for direct inspection. Surgeons prefer an inguinal approach when they suspect malignancy, because it allows early control of the spermatic cord vessels. The operative steps relevant to coding and documentation are:

1. Incision (scrotal or inguinal) with delivery of the testis into the operative field
2. Visual and tactile examination of the tunica albuginea, epididymis, and spermatic cord
3. Decision on biopsy: If indicated, a core or incisional biopsy is taken and the specimen sent for histopathology
4. Haemostasis and closure of the tunica, dartos, and skin layers

If a biopsy is taken, the pathology provider bills the histopathology report separately. That laboratory fee is not part of N1350. Even so, an operative note that describes a biopsy with no matching pathology report in the record can trigger an audit query. The surgeon’s operative note is the primary evidence for the N1350 claim.

Clinical indications for N1350

The clinical scenario drives both the documentation and the insurer’s willingness to cover the procedure. Common indications where N1350 applies include:

• Suspected testicular torsion: Exploration is performed urgently to assess viability and detorse the testis. Even when no biopsy is taken, the exploration itself warrants N1350.
• Palpable testicular mass of uncertain nature: Pre-operative imaging may be inconclusive; exploration provides direct visualisation and allows biopsy if a lesion is found.
• Azoospermia or infertility workup: Testicular biopsy establishes the presence or absence of spermatogenesis. This indication carries specific policy exclusion risks (see infertility section below).
• Trauma: Testicular rupture assessment may require surgical exploration and repair.
• Undescended testis assessment: Where orchidopexy is not yet appropriate, exploration alone confirms testicular position and viability.

Each indication changes what the operative note must demonstrate to validate the claim. For torsion cases, timing (onset-to-surgery interval) and viability findings matter.

For mass cases, the biopsy result and pre-operative imaging correlation are relevant. Coders and practice managers should confirm the documented indication matches the insurer-approved clinical category before submitting.

What N1350 includes and excludes

Understanding the scope of N1350 prevents both undercoding (missing procedures) and upcoding (claiming codes that were not performed). The table below summarises the key inclusions and exclusions.

Related and neighbouring CCSD codes

Several CCSD codes sit next to N1350 in the genitalia section. Knowing when each one applies prevents the most common coding errors in scrotal and testicular surgery. Varicocele surgery, for instance, has an entry of its own, N1900. Removal of one whole epididymis, a unilateral epididymectomy, is billed under N1520. Our Bupa CCSD code guidance shows how these codes map to Bupa’s fee schedule. Every neighbouring code also has its own page in our CCSD code library.

For fee amounts by insurer, the Healix fee schedule publishes CCSD-coded surgical fees.

Key coding decision: If exploration reveals a tumour that needs immediate removal, the orchidectomy code replaces N1350 rather than being added to it. That is usually N0680 for an inguinal orchidectomy with the spermatic cord. A laparoscopic removal is N0630, and removal of both testes is N0500. If the surgeon removes only the tumour and keeps the testis, the claim moves to N0700, excision of lesion of testis.

The exploration counts as part of the orchidectomy when both happen in the same session, so record that clearly in the operative note.

Fixation follows the same rule. If the surgeon explores both testes and then fixes them, bill N0820 in place of N1350, and use N0920 when only one side is fixed. An abdominal testis once had a code of its own, N0930, but the schedule has listed it as inactive since January 2009. The diagram below maps each outcome in theatre to its code.

Documentation requirements for a valid N1350 claim

An incomplete operative note is the primary audit trigger for N1350 claims. The insurer’s clinical reviewer needs to reconstruct the procedure from the note alone, so every element below must appear for the claim to withstand scrutiny.

• Clinical indication: The reason for exploration stated explicitly (e.g. suspected torsion, palpable mass, azoospermia workup).
• Surgical approach: Scrotal or inguinal incision; side (left, right, bilateral).
• Intraoperative findings: What was found on examination of the tunica albuginea and epididymis. Vague entries (“normal appearance”) are weak; specific findings (“no torsion identified, epididymis unremarkable, tunica intact”) are stronger.
• Biopsy decision: Whether a biopsy was taken, the technique (core or incisional), and the fact that the specimen was sent for histopathology. If no biopsy was taken, state that explicitly.
• Closure: Layer-by-layer closure documented.
• Pathology request: Where a biopsy was taken, the histopathology request form or laboratory requisition provides corroborating evidence.

In Pabau, the practice management platform we build, an operative note template can carry a field for each element above. The note is then complete before it is signed. Practices on paper records often find the biopsy decision or closure details missing when an insurer queries the claim months later.

Pre-authorisation for N1350: Which insurers require it

Pre-authorisation rules differ between insurers, but most major UK private medical insurers (PMIs) require authorisation before N1350 is performed. A claim with no authorisation number, or with one obtained after a non-emergency procedure, is the most common cause of N1350 denials.

The table below reflects general insurer policy. Verify current requirements with each insurer, because policies are updated annually.

Emergency exception: When N1350 is performed as an emergency (suspected torsion), most insurers accept retrospective authorisation obtained within 24-48 hours of surgery. Document the emergency clearly in the operative note and notify the insurer as soon as the patient is stabilised.

How to submit an N1350 claim via Healthcode

Healthcode is the standard EDI claims platform for UK private practice surgical billing. Most major insurers receive N1350 claims via Healthcode’s secure portal. The submission steps are:

1. Open a new claim in Healthcode and select the insurer, member reference number, and treating consultant details.
2. Enter procedure code N1350 in the procedure line. Do not add a separate biopsy code if a biopsy was performed. It is included in N1350.
3. Attach the pre-authorisation number in the designated field. A claim submitted without a valid pre-auth number will be rejected at the portal level before it reaches the insurer’s clinical team.
4. Add the diagnosis code using the ICD-10 code that matches the documented clinical indication.
5. Link the anaesthetist’s claim if applicable. Healthcode lets you associate the surgical and anaesthetic claims so the insurer can process them together.
6. Add the bilateral modifier if both testes were explored (see bilateral rules below).
7. Submit and retain the submission reference for follow-up if the claim is queried.

Common portal-level errors include entering N1350 with an extra biopsy code and omitting the pre-auth number. Another is a consultant name that doesn’t match the insurer’s panel record.

Bilateral procedures and modifier rules

When both testes are explored in the same operative session, the billing approach varies by insurer. No single UK-wide rule covers all PMIs, so practices should check the current insurer guide before submitting.

• Some insurers accept N1350 listed twice on the same claim, with the second line carrying a bilateral or second-side modifier. Each line is typically reimbursed at a reduced rate (commonly 50% of the second procedure).
• Others require a bilateral modifier added to a single N1350 line, with the insurer applying its bilateral fee rule automatically.
• Bupa’s bilateral rules are set out in the Bupa provider guide. The first procedure is reimbursed in full and the second at a reduced percentage. Verify the current percentage before invoicing.
• Document both sides explicitly in the operative note: Approach (scrotal or inguinal) for each side, findings for each testis, and biopsy decision for each. A single operative note that covers both testes in a single narrative is acceptable, but both sides must be named.

Common claim denial reasons for N1350 and how to avoid them

Claim denials for CCSD Code N1350 follow predictable patterns. The table below maps the most common denial reasons to their root cause and the fix.

N1350 and infertility investigations: The policy exclusion trap

Most UK private medical insurance policies exclude a testicular biopsy performed as part of an azoospermia or male infertility workup. The exclusion applies even though N1350 is a surgical code. The operation itself looks the same as an exploration performed for any other indication.

Insurers apply the exclusion based on the documented clinical indication, not the procedure code. A claim with an indication of “infertility investigation” or “azoospermia workup” is typically denied under the fertility exclusion clause.

Correct coding of N1350 does not change that. The insurer is excluding the reason for surgery, not the surgery itself.

What practices need to do before the patient is listed for surgery:

• Check the patient’s specific policy wording for the fertility or infertility exclusion clause. Exclusion wording varies between insurers, and even between policies from the same insurer.
• If infertility is the primary indication, advise the patient at consultation that the procedure will likely need to be self-funded.
• Do not document a different indication to avoid the exclusion. Recording a secondary clinical concern (e.g. a palpable epididymal change noted at consultation) is clinically legitimate only if it was genuinely observed and documented contemporaneously.
• Obtain written confirmation from the insurer that the procedure is covered under the patient’s policy before admission, referencing the specific indication stated in the referral.

How practice management software supports accurate N1350 billing

A private urology practice billing several insurers usually keeps authorisations in one place, operative notes in another and claims in a third. For N1350, the pressure points are the authorisation status before surgery day and a complete operative note before submission.

Pabau’s claims management software submits CCSD-coded claims to UK insurers through Healthcode and Bupa. The authorisation code, its dates and its sessions sit on the patient’s case, and Pabau warns you when one is missing.

When an insurer queries an N1350 claim months later, the operative note and the authorisation are in the same record.

Practices that track authorisations in a spreadsheet often find the number missing, or stored apart from the billing system. That situation sits behind the most common N1350 denial.

Manage CCSD billing without the admin overhead

Pabau tracks pre-authorisation on the patient’s case and submits CCSD-coded claims through Healthcode. UK urology practices bill surgery from the same record that holds the operative note.

Book a demo

Conclusion

N1350 rewards precision on two points. The code already includes the biopsy, and it stops applying the moment the testis is fixed or removed. Code what happened in theatre rather than what was planned, and the claim matches the operation.

The denials that remain come from paperwork, not coding. Confirm the patient’s policy covers the indication before listing, and obtain the authorisation before a non-emergency operation.

Then check that the operative note names the approach, the findings and the biopsy decision. Book a demo to see how Pabau keeps authorisations, operative notes and CCSD claims in one record for UK urology practices.

Continue your research

Choosing billing software for a UK private practice? Best medical billing software in the UK compares the systems that submit claims to UK private insurers.

Frequently asked questions